Hjem › Brystkreft › Iowa
Kliniske studier for Brystkreft i Iowa
22 studier for Brystkreft søker deltakere på steder i Iowa.
Byer i Iowa
Offisiell studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- og 12 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Accellacare of McFarland, Ames
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07102381Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- University of Iowa Hospitals and Clinics, Iowa City
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06324357A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Des Moines
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06103864A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Local Institution - 0065, Iowa City
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06618287A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- University of Iowa, Iowa City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07174336A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Mission Cancer and Blood, Des Moines
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06492616BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
- University of Iowa Hospitals and Clinics, Iowa City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06756932Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- og 17 flere
RekruttererFase 3
Alder 18 til 60 · Kvinner · Oppdatert 2. sep. 2026 · NCT05879926A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- University of Iowa, Iowa City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07029399Exercise Oncology Clinic Pilot Feasibility Trial
- University of Iowa Health Care, Iowa City
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT07765927Breast Cancer PSMA PET
- University of Iowa Healthcare, Iowa City
RekruttererTidlig fase 1
Alder 18 til 90 · Kvinner · Oppdatert 6. aug. 2026 · NCT06586047E-Mindfulness Approaches for Living After Breast Cancer
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
- Saint Anthony Regional Hospital, Carroll
- og 10 flere
RekruttererFase 3
Alder 18 til 50 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06748222First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- University of Iowa, Iowa City
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
- Iowa Holden Comprehensive Cancer Center, Iowa City
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT06169371Integrated Cancer Repository for Cancer Research
- Methodist Jennie Edmundson Hospital, Council Bluffs
- Covenant Medical Center, Inc, Waterloo
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Iowa Health Care, Iowa City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. jun. 2026 · NCT05283330De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- og 11 flere
RekruttererFase 3
Alder 50 til 70 · Alle kjønn · Oppdatert 23. apr. 2026 · NCT04852887Quantitative MRI Assessment of Breast Cancer Therapy Response
- University of Iowa, Iowa City
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 17. apr. 2026 · NCT05704062Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
- Physicians' Clinic of Iowa PC, Cedar Rapids
- og 10 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Iowa City
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Medical Oncology and Hematology Associates-West Des Moines, Clive
- Mercy Cancer Center-West Lakes, Clive
- Mercy Medical Center - Des Moines, Des Moines
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. okt. 2025 · NCT03418961Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.